Nektar Therapeutics (NKTR) Non-cash Items (2011 - 2013)
Nektar Therapeutics (NKTR) recorded quarterly Non-cash Items of $56.3 million in Q4 2013, up 418287.98% quarter-over-quarter from $13449.0 in Q4 2012, and up 418287.98% on a YoY basis from N/an in Q4 2012.
Nektar Therapeutics (NKTR) Non-cash Items (2011 - 2013) Analysis & Trends
Nektar Therapeutics' Non-cash Items history runs 3 years deep, the most recent figure standing at $56.3 million for Q4 2013.
- In Q4 2013, Non-cash Items rose 418287.98% year-over-year to $56.3 million; the TTM figure through Dec 2013 stood at $56.3 million (up 418287.98% YoY), while the FY2013 annual figure was $56.3 million, up 418287.98% from the prior year.
- Non-cash Items was $56.3 million for Q4 2013 at Nektar Therapeutics, up from $13449.0 in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $56.3 million in Q4 2013 to a low of $13449.0 in Q4 2012.
- Historically, Non-cash Items has averaged $22.5 million across 3 years, with a median of $11.2 million in 2011.
- The sharpest annual moves came in 2012 and 2013: Non-cash Items tumbled 99.88% in 2012, then surged 418287.98% in 2013.
- A 3-year view of Non-cash Items shows it stood at $11.2 million in 2011, then sank by 99.88% to $13449.0 in 2012, then soared by 418287.98% to $56.3 million in 2013.
- The last three Non-cash Items figures came in at $56.3 million (Q4 2013), $13449.0 (Q4 2012), and $11.2 million (Q4 2011), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Nektar Therapeutics | 1.51 Bn | 939.55 Mn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 56.27 Mn |
| Dec 31, 2013 | 56.27 Mn |
| Dec 31, 2012 | 13,449.00 |
| Dec 31, 2012 | 13,449.00 |
| Dec 31, 2011 | 11.17 Mn |
| Dec 31, 2011 | 11.17 Mn |